2014-11-18T11:48:04-06:00 2013-12-31 KPMG LLP 1676 International Drive McLean VA 22102 990 2013-01-01 237311318 DRUG INFORMATION ASSOCIATION INC % BAYARD G GARDINEER III DRUG 2154426100 800 ENTERPRISE ROAD Suite 200 HORSHAM PA 19044 BAYARD GARDINEER CHIEF FINANCIAL OFFICER 2154426100 2014-11-17 true RAYMOND LY P01205643 2154426100 2014-11-13 2013 2015-11-30 17:44:51Z BARBARA LOPEZ KUNZ 800 enterprise road horsham PA 19044 25651833 false X WWW.DIAHOME.ORG X 1964 MD ATTACHMENT 1 22 21 112 3007 534976 3712 0 0 25838696 24205703 1086555 1149949 -54353 93915 26870898 25449567 112991 855 0 0 11176607 9974542 0 0 0 18379690 16769766 29669288 26745163 -2798390 -1295596 19398220 18385838 9475147 9971356 9923073 8414482 X DIA FOSTERS INNOVATION TO IMPROVE HEALTH AND WELL BEING WORLDWIDE BY: PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; DELIVERING CUSTOMIZED LEARNING EXPERIENCES; BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY. false false 8113977 18261847 The number of meetings and workshops held has increased from a total of two events held in the United States in 1980, to a total of 368 events held worldwide in 2013. In 2013, DIA conducted 193 workshops and training courses in the United States with over 7,400 participants. In addition to these events, the DIA Annual Meeting, the leading global conference on pharmaceutical information and education, attracted over 6,700 participants from the US and across the world. In 2013, DIA conducted 92 workshops and training courses across Europe, attracting over 3,100 participants. In addition, the Annual DIA Euro Meeting, which attracted over 2,200 participants, is recognized as one of the premier forums for exchange of information in the European medical/pharmaceutical community. In 2013, DIA conducted 14 educational events in Japan, attracting over 2,300 participants from Japan and other countries. In 2013 DIA conducted 6 educational events in India, with participation of over 700 persons. In 2013, DIA conducted 11 events in China, attracting over 1,700 participants . In addition, DIA conducted 1 educational program events in Latin America, with participation of over 360 persons. With an on-going commitment to internet technology-based learning, DIA continued to expand its global reach and advance its mission by offering various workshops in electronic webinar format. In 2013, DIA conducted 49 webinars, attracting over 250 individual and group participants. 1651055 3427926 In 2013 DIA conducted 193 workshops and training courses in the United States with over 7,400 participants. In 2013, DIA conducted 92 workshops and training courses across Europe, attracting over 3,100 participants. With an on-going commitment to internet technology-based learning, DIA continued to expand its global reach and advance its mission by offering various workshops in electronic webinar format. In 2013 DIA conducted 49 webinars, attracting over 250 individual and group participants. 571533 593757 PUBLICATIONS Therapeutic Innovation & regulatory Science publication is a newly launched Journal which rebrands the Drug Information Journal, which DIA proudly published for 46 years. The scope of Therapeutic Innovation & regulatory Sicence reaches beyond pharmaceutical research and development to include innovations in drugs, devices and diagnostics, as well as global regulatory issues. It is published bi-monthly, in periodical form. All eligible members (approx. 15,200) receive the publication in electronic format. 9550198 20665 1938650 19886763 true false false false false false false false false false true false false false true true false true false true true true false false false false false true false true false false false false false false false false false false false false true true true false false false true X 118 0 true 112 true true true true JA IN CH SZ false false false false false false false false X 22 21 false false false false true true true true true false true true true true true true true true true true false X BAYARD G GARDINEER III 2154426126 800 ENTERPRISE RD SUITE 200 HORSHAM PA 19044 YVES JUILLET MEMBER 5.0 X 0 0 0 LING SU IMMEDIATE PAST PRESIDENT 10.0 X X 0 0 0 MINNIE BAYLOR-HENRY President Elect 10.0 X X 0 0 0 STEVE CAFFEE MEMBER 5.0 X 0 0 0 SERGIO GUERRERO MEMBER 5.0 X 0 0 0 TRUUS JANSE-DE HOOG MEMBER 5.0 X 0 0 0 TATSUO KUROKAWA MEMBER 5.0 X 0 0 0 SANDRA L KWEDER MEMBER 5.0 X 0 0 0 JENNIFER L RIGGINS MEMBER 5.0 X 0 0 0 JOHN A ROBERTS Treasurer 10.0 X X 0 0 0 LARISA NAGRA SINGH MEMBER 5.0 X 0 0 0 PER SPINDLER PRESIDENT ELECT 10.0 X X 0 0 0 BEAT E WIDLER MEMBER 5.0 X 0 0 0 NING XU MEMBER 5.0 X 0 0 0 MICHELE C LIVESEY MEMBER 5.0 X 0 0 0 SANDRA A MILLIGAN MEMBER 5.0 X 0 0 0 Frances JRichmond MEMBER 5.0 X 0 0 0 Gesine Bejeuhr MEMBER 5.0 X 0 0 0 Nancy Dreyer MEMBER 5.0 X 0 0 0 Andrez Czarnecki Member (FROM 6/2013) 5.0 X 10500 0 0 Durhane Wong-Rieger Member 5.0 X 0 0 0 Peter Bachmann Member 5.0 X 0 0 0 CARLOS FULCHER WW DEPUTY EXEC-DIR(THRU 11/13) 37.5 X 233287 0 8121 Paul Pomerantz Executive Director (THRU 3/13) 37.5 X 83822 0 4600 Barbara Lopez Kunz Global Chief Executive 37.5 X 288462 0 12688 Bayard Gardineer CFO/Worldwide Director 37.5 X 195612 0 14111 SUSAN CANTRELL DIRECTOR OF DIA AMERICAS 37.5 X 281786 0 33720 ELIZABETH LINCOLN DIRECTOR OF GLOBAL ENGAGEMENT 37.5 X 140559 0 11124 JANE CAI DIRECTOR-CHINA 37.5 X 174505 0 27646 Jyette Lyngvig Director - EMEA 40.0 X 278198 0 59688 CHERYL BYRNE CONTROLLER 37.5 X 120257 0 17524 ALEJANDRO BERMUDEZ DEL VILLAR PROJECT CO-ORDINATOR 37.5 X 130000 0 7169 LORRAINE RISBOSKIN ASSOCIATE DIRECTOR - PLANNING 37.5 X 121176 0 17603 JENNIFER ANDREE-WEBB ASSOCIATE DIRECTOR 37.5 X 121176 0 30027 Judith Connors Associate Director 37.5 X 112284 0 10003 2291624 0 254024 15 false true false International ExhibitIon Congress EUROPAPLEIN AMSTERDAM 0 NL 1078 GZ MEETING CONV. CENTER 903670 Levy Restaurants 415 Summer Street BOSTON MA 02210 Catering Services 639308 Amsterdam Rai PO BOX 77777 AMSTERDAM 0 NL Event Venue Mgmt Svc 540879 Fierce Markets Inc 1900 L Street Ste 400 WASHINGTON DC 20004 Advertising Services 345000 AV Experience Inc 825-43 AVENUE LCHINE QUEBEC 0 CA H8T2J6 Business Services 350689 31 0 MEETINGS AND WORKSHOPS 611710 18261847 18261847 TRAINING 611710 3427926 3427926 PUBLICATIONS 900004 593757 58781 534976 MEMBERSHIP DUES 900099 1922173 1922173 24205703 1149949 1149949 0 0 255383 202266 53117 0 53116 53116 0 0 0 0 OTHER INCOME 900099 16478 16478 FOREIGN CURRENCY TRANSLATION INCOME(LOSS) 900099 24321 24321 40799 25449567 23711526 534976 1203065 0 0 855 855 0 0 0 0 1502707 991787 510920 0 0 0 0 0 6438937 4249698 2189239 0 514543 339598 174945 0 908523 599625 308898 0 609832 402489 207343 0 0 0 0 0 150299 23429 126870 0 164773 3291 161482 0 0 0 0 0 0 0 0 0 0 0 80196 46131 34065 0 545652 0 545652 0 157395 103881 53514 0 246489 162683 83806 0 0 0 0 0 769142 507634 261508 0 795065 524683 270382 0 175 175 0 0 60363 46575 13788 0 56537 0 56537 0 0 0 0 0 469770 310048 159722 0 138957 91712 47245 0 MEETING AND WORKSHOP EXPENSE 8113977 8113977 TRAINING EXPENSE 1651055 1651055 PUBLICATIONS 571533 571533 RECRUITEMENT & RELATED COSTS 512381 44910 467471 2286007 1100994 1185013 26745163 19886763 6858400 0 0 0 1720754 1459101 0 0 332030 386591 0 0 0 0 0 0 0 0 1214138 1201963 10834160 4605354 6406609 6228806 9604482 8916592 0 0 0 0 0 0 120207 192785 19398220 18385838 2984769 3162248 0 0 4983944 4799084 0 0 0 0 0 0 0 0 1500000 2000000 6434 10024 9475147 9971356 X 9923073 8414482 0 0 0 0 9923073 8414482 19398220 18385838 X -1295596 -212995 X false true X true false X 2258742 2162718 2136971 1959048 1922173 10439652 26063903 24287432 26478746 23066783 21945156 121842020 0 0 0 28322645 26450150 28615717 25025831 23867329 132281672 0 0 0 132281672 1883998 1495316 0 1099135 1149949 5628398 0 1883998 1495316 0 1099135 1149949 5628398 0 275000 4738 2136 3075 40799 325748 30481643 27950204 28617853 26128041 25058077 138235818 0.95693 0.96215 0.04072 0.03587 X 2589372 2589372 5609938 2430121 3179817 118778 103628 15150 2077156 1688970 388186 438916 382635 56281 6228806 0 SECURITY DEPOSIT PAYABLE 10024 10024 X 28671314 3221747 3221747 25449567 25449567 30179905 3434742 3434742 26745163 26745163 SCHEDULE D, PART X DIA, INC. IS A U.S. ENTITY EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE AND IS A NONTAXABLE MEMBERSHIP ASSOCIATION UNDER SWISS LAW. MANAGEMENT MONITORS THE ASSOCIATION'S ACTIVITIES AND CONSIDERS THE POTENTIAL FOR INCOME TAXES WHEN ACTIVITIES ARE NOT RELATED TO ITS EXEMPT PURPOSE. MANAGEMENT HAS REVIEWED TAX POSITIONS TAKEN IN FILINGS WITH U.S. JURISDICTIONS AND BELIEVES THOSE POSITIONS WOULD BE SUSTAINED SHOULD THE FILINGS BE EXAMINED BY THE RELEVANT TAXING AUTHORITY. SHOULD SETTLEMENT OF AN EXAMINATION OR OTHER EVENT RESULT IN A CHANGES IN MANAGEMENT'S EVALUATION OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN FILINGS THAT HAVE NOT BEEN CLOSED BY STATUE OR EXAMINATION, ANY ADDITIONAL INTEREST AND PENALTIES RELATED TO THE UNRECOGNIZED TAX BENEFIT AS A RESULT OF THE UNCERTAIN TAX POSITION WILL BE INCLUDED IN OPERATING EXPENSES. SCHEDULE D, PART XI, LINE 2D SUBSIDIARIES REVENUE $3,019,481 RENTAL EXPENSES 202,266 --------- TOTAL $3,221,747 ========= SCHEDULE D, PART XII, LINE 2D SUBSIDIARIES EXPENSE $3,232,476 RENTAL EXPENSES 202,266 --------- TOTAL $3,434,742 ========= true Europe (Including Iceland and Greenland) 1 20 Program Services Workshops & Training 7307941 South Asia 1 6 Program Services Workshops & Training 240976 South Asia 1 8 Program Services Workshops & Training 1646769 South Asia 1 7 Program Services Workshops & Training 1357069 4 41 4 41 10552755 10552755 true false true false false true FORM 990, SCHEDULE F, PART 1 DEPENDING ON THE USE OF FUNDS (E.G. EDUCATIONAL PROGRAMS, RESEARCH, MEETING ATTENDANCE, ETC.), EACH GRANTEE IS REQUIRED TO REPORT TO DIA MANAGEMENT, ON A REGULAR SCHEDULE, THE FOLLOWING: DETAILED PROGRAM CONTENT DOCUMENTS; NUMBER OF PARTICIPANTS; ONGOING RELEVANCE OF SUBJECT MATTER TO DIA'S MISSION; ACTUAL VS. PROPOSED TIMELINE; PROOF OF BUDGETARY ALLOCATION TO TIMELINE; REVISED TIMELINE FOR GRANT CYCLE; PROJECTED OUTCOME OF PROJECT; AND A FINAL REPORT ON THE OUTCOME OF THE PROJECT. true SCHEDULE I, PART 1, LINE 2 DEPENDING ON THE USE OF FUNDS (E.G. EDUCATIONAL PROGRAMS, RESEARCH, MEETINY attendance, etc.), each grantee is required to report to DIA management, on a regular schedule, the following: detailed program content documents; number of participants; ongoing relevance of subject matter to DIA's mission; actual vs. proposed timeline; proof of budgetary allocation to timeline; revised timeline for grant cycle; projected outcome of project; and a final report on the outcome of the project. X X X X false false false false false false false false false CARLOS FULCHER WW DEPUTY EXEC-DIR(THRU 11/13) 213825 0 19462 0 0 0 6454 0 1667 0 241408 0 0 0 SUSAN CANTRELL DIRECTOR OF DIA AMERICAS 256786 0 25000 0 0 0 17850 0 15870 0 315506 0 0 0 JENNIFER ANDREE-WEBB ASSOCIATE DIRECTOR 114469 0 6707 0 0 0 8013 0 22014 0 151203 0 0 0 ELIZABETH LINCOLN DIRECTOR OF GLOBAL ENGAGEMENT 134259 0 6300 0 0 0 9489 0 1635 0 151683 0 0 0 JANE CAI DIRECTOR-CHINA 169505 0 5000 0 0 0 11865 0 15781 0 202151 0 0 0 Barbara Lopez Kunz Global Chief Executive 138462 0 150000 0 0 0 9692 0 2996 0 301150 0 0 0 Bayard Gardineer CFO/Worldwide Director 174312 0 21300 0 0 0 12293 0 1818 0 209723 0 0 0 Jyette Lyngvig Director - EMEA 268233 0 9965 0 0 0 54959 0 4729 0 337886 0 0 0 FORM 990- PART III LINE 4D PROGRAM SERVICE The Association maintains a Philanthropy Committee that serves as a vehicle of support for ongoing study of drug information. The committee receives grant proposals and other requests, evaluates them and awards grants, fellowships and other support used to train qualified scientists in clinical pharmacology, pharmacoepidemiology, drug evaluation, and drug regulation. A grant program also exists to advance the study of drug information in academic institutions. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS MEMBERS WHO PAY DUES BUT HAVE NO OWNERSHIP INTEREST IN THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER IS ENTITLED TO ONE VOTE TO ELECT DIRECTORS, ONE VOTE TO ELECT OFFICERS AND ONE VOTE TO CHANGE THE BY-LAWS OF THE ORGANIZATION. SERVICE AS OFFICER AND/OR BOARD DIRECTOR IS ON A VOLUNTEER BASIS. FORM 990, PART VI, SECTION A, LINE 7B EACH MEMBER OF THE BOARD (THE GOVERNING BODY) IS DULY ELECTED BY A PROXY VOTE OF THE MEMBERSHIP. THE ORGANIZATION'S BY-LAWS DEFINE THE DUTIES, RESPONSIBILITIES AND POWERS OF THE BOARD, INCLUDING THOSE ACTIONS SUBJECT TO MEMBERSHIP APPROVAL. FORM 990, PART VI, SECTION B, LINE 11A THE DRAFT 990 IS REVIEWED JOINTLY BY THE EXECUTIVE DIRECTOR, THE CFO AND THE FINANCE COMMITTEE CHAIR. AFTER THIS REVIEW IS COMPLETE, A COPY OF THE FINAL RETURN IS PROVIDED TO EACH SITTING BOARD MEMBER. AFTER EACH BOARD MEMBER RECEIVES A FINISHED COPY, THE COMPLETE RETURN IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C PERIODICALLY MANAGEMENT EVALUATES ALL EXISTING PAID VENDOR RELATIONSHIPS FOR GOODS AND/OR SERVICES. THEY ASSESS THE PARTIES INVOLVED AND THE RELATIONSHIPS BETWEEN THEM AND DIA. WHERE CONFLICTS WITH STANDING POLICY MAY DEVELOP OR EXIST, APPROPRIATE CORRECTIVE ACTIONS ARE TAKEN, UP TO AND INCLUDING REPLACEMENT OF THE VENDOR WITH A SUITABLE AND QUALIFIED SUBSTITUTE THAT POSES NO CONFLICT OF INTEREST. NEW VENDORS ARE EVALUATED TO DETERMINE IF POTENTIAL CONFLICTS EXIST BEFORE APPROVAL OF ANY PAID RELATIONSHIP IS GRANTED. FORM 990, PART VI, SECTION B, LINE 15A & 15B ON A REGULAR BASIS, BUT NO LESS THAN BIENNIALLY, THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE COMPLETE COMPENSATION PACKAGES OF ALL UPPER MANAGEMENT LEVEL EMPLOYEES TO ENSURE THEY ARE COMPLIANT WITH ALL APPLICABLE LAWS AND CONSISTENT WITH THE PROVISIONS OF STANDING COMPENSATION POLICY. THIS INCLUDES SALARY, BENEFITS, BONUSES AND OTHER PAYMENTS MADE TO BOTH SENIOR MANAGEMENT AND ALL OTHERS DEEMED TO BE SUBJECT TO COMPENSATION REVIEW. THE COMPENSATION COMMITTEE OBTAINS AND RELIES UPON COMPARABLE DATA IN THE SAME OR SIMILAR COMMUNITIES FOR SIMILAR SERVICES. THE REVIEW PROCESS AND BASIS FOR COMPENSATION PACKAGES IS ADEQUATELY DOCUMENTED. THE RESULTS OF THE EVALUATION ARE PRESENTED TO THE BOARD OF DIRECTORS IN A FORMAL, WRITTEN COMPENSATION REPORT. FORM 990, PART VI, SECTION C, LINE 19 DIA'S FORM 990 AND FORM 990-T ARE AVAILABLE UPON REQUEST. THE FORM 990 IS ALSO AVAILABLE ON GUIDESTAR.COM. THE ORGANIZATION'S BYLAWS ARE AVAILABLE TO THE PUBLIC ON ITS WEBSITE. CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION A BOARD MEMBER ANDREZ CZARNECKI WAS AN EDITOR WHOM RECEIVED HONARARIUM UNTIL MAY 2013. IN JUNE 2013 MR. CZARNECKI BECAME A BOARD MEMBER AND RESIGNED FROM THE EDITOR POST. THE COMPENSATION REPORTED ON PART VII REPRESENTS PAYMENT FOR SERVICES AS AN EDITOR. FORM 990, PART XI, LINE 9 SUBSIDIARY REVENUE $3,019,481 SUBSIDIARY EXPENSE 3,232,476 --------- TOTAL $ (212,995) ========= DRUG INFORMATION ASSOCIATION LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 DRUG EDUCATIO PA 28997 50852 DIA DIA GLOBAL HEALTHCARE LLC 800 ENTERPRISE ROAD SUITE 200 HORSHAM PA 19044 DRUG EDUCATIO PA 11 10000 DIA DIA (INDIA) PRIVATE LIMITED A303 ANDHERI KURLA RD MAROL ANDHERI MUMBAI India IN 400 059 SCIENTIFIC EDU IN DIA INC PRIVATE LTD 168764 75300 1.00000 true DIA EUROPE GMBH Kuechengasse 16 POSTFACH BASEL SZ 4002 SCIENTIFIC EDU SZ DIA INC LLC 155250 534576 1.00000 true DIA E-LEARNING EUROPE GMBH Kuechengasse 16 POSTFACH BASEL SZ 4002 SCIENTIFIC EDU SZ DIA INC LLC 74 20997 1.00000 true DIA (BEIJING) HEALTHCARE INFORMATION GATEWAY PLAZA BEIJING CH SCIENTIFIC EDU CH DIA GLOBAL PRIVATE LLC 1333599 204181 1.00000 SH DIA Japan Nisso 22 Bldg 7F Minato-Ku Tokyo JA SCIENTIFIC EDU JA dia llc GIC 1379598 220569 1.00000 false true false false false false false false false false true true true false true false true true DIA (India) Private Limited B 110000 FMV DIA (Beijing) Healthcare Information Consulting Ltd B 60015 FMV